7th Annual Patient Recruitment & Retention America Summit
23 - 25 OCTOBER 2018
Director Clinical Management
Global Feasibility Operations Director Center
Clinical Innovation Lead
PAST CASE STUDIES INCLUDE
Angelique HOPKINSAssociate Director Clinical Trial Analytics
Will the struggle to meet the enrollment quotas while keeping costs under control continue?
The extremely competitive landscape in oncology clinical trials has led to more complex study designs that require larger patient accrual targets in shorter recruitment periods. The usual strategies for addressing these constraints are often costly and ineffective from an operation cost-benefit perspective. This presentation will explore the analytics behind this growing trend and explore whether this is the new industry norm.
- Current saturation in Oncology
- Trial timeline, increasing patient targets, decreasing recruitment rates
Christine SEYMOURClinical Development Programs Director
The patient engagement value model
This session will present how Ipsen has developed a patient focused clinical development model to give patients better and quicker access to a new or improved solutions of care, though a better understanding of patient perspective and improved communication on Ipsen research activities.
- The challenges and obstacles to overcome
- Recommendations for clinical study feasibility
- Implementation of more patient centric protocol designs
- Study awareness increase through digital tools
Elizabeth ARMSTRONGDirector Clinical Management
Retention and avoidance of missing data in a rare disease clinical trial
In 2010, the National Research Council’s Panel on handling missing data in clinical trials made 18 recommendations challenging the industry to avoid and account for missing data. With the understanding that patient’s participation in clinical trials is by voluntary consent, how can we operationalize the retention of subjects? Methods and outcomes will be covered in this presentation.
- Trial Design Options
- Informed Consent Options
- Managing Assessments
- Investigator Communications
Katie KINGPatient Recruitment Strategist
Patient first approach is a key to a successful clinical trial
In an effort to adopt patient centric practices, it has become increasingly common for key industry stakeholders to solicit patient feedback on clinical trial protocol elements, recruitment and retention strategies, and other operational aspects of clinical trial implementation. While this collaborative, data-driven approach to trial design and conduct is certainly a step in the right direction, it does not necessarily result in improvements to the clinical trial patient experience. Only by developing a thorough understanding of patient populations and by authentically honoring their needs in a patient-first approach, is industry able break down common barriers to recruitment and retention resulting in not only successful clinical trials, but also positive patient experiences.
- Patient-first approaches
- Patient experience
- Patient engagement
WE ARE LOOKING FORWARD TO WELCOMING YOU ON BOARD IN 2018!
2017 CONFERENCE TOPICS
- The real-world patient front and center
- Digital patient recruitment
- Patient Centric approach- key to successful clinical trial
- Importance of positive patient experience
- Data driven clinical trial and patient recruitment
- Challenging rare disease patient recruitment
- Efficient recruitment initiatives
- Keeping costs of clinical trials under control
- Clinical operations optimization
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors, Heads of departments from pharmaceutical industry involved in:
- Clinical Development
- Clinical Program Management and Development
- Clinical Trials
- Clinical Trial Analytics
- Clinical Operations
- Patient Recruitment and Engagement
- Clinical Innovation
- Medical Affairs
- Patient and Investigator Relations
- Patient Engagement
- Clinical Development Programs
Clinical operations optimization
- How to achieve operational excellence and what are the current challenges?
- Speeding up clinical trials- what works and what does not?
- How to efficiently manage financial resources during the trial?
- Data collecting methods and their efficiency
- How to be moving towards data transparency?
The future of clinical trials
- How about expending patient interaction beyond the controlled clinical trial setting?
- How to engage healthcare providers and encourage more clinical trial referrals?
- Emerging need for harmonization of companies’ policies and processes in conducting clinical trials.
- Need to realize the growing importance of the internet role in patient’s path to treatment
- What is the outlook in the field in the near future?